Streetbeat News

Stock Prices

AIM

AIM ImmunoTech Inc announced that Roswell Park Comprehensive Cancer Center has reported positive topline data from its Phase 1 study evaluating Ampligen as a treatment for early-stage triple-negative breast cancer. The results confirmed that the treatment was well tolerated and showed promising clinical activity. A Phase 2 study is planned to determine if Ampligen may be a safe and effective alternative to pembrolizumab or pembrolizumab/NAC. Following the announcement, AIM shares are up 6.26% at $0.62.

Portfolio Pulse from Vandana Singh

September 11, 2023 | 5:58 pm

BCYC

B. Riley Securities analyst Kalpit Patel has upgraded Bicycle Therapeutics (NASDAQ:BCYC) from Neutral to Buy, while maintaining the price target at $33.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 5:58 pm

TLRY

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) are trading higher due to continued momentum in the cannabis sector, driven by U.S. efforts to reschedule marijuana. The stock has seen heavy trading volume with over 43 million shares traded, compared to its 100-day average of 27.631 million shares. TLRY shares are up more than 45% over the last 30 days.

Portfolio Pulse from Erica Kollmann

September 11, 2023 | 5:57 pm

STLA

A strike by United Auto Workers (UAW) at General Motors Co, Ford Motor Co, and Stellantis NV would not cause a recession, according to RSM US LLP economist Joseph Brusuelas. A Michigan-based economic consultancy estimated a $5.6 billion potential loss to the U.S. GDP for a 10-day strike by the UAW. However, Brusuelas believes the economy could only suffer a modest 0.2% drag this quarter if the action lasts for a month.

Portfolio Pulse from Shivani Kumaresan

September 11, 2023 | 5:53 pm

MRKR

Marker Therapeutics Inc (NASDAQ:MRKR) released preliminary results of the first participant treated with MT-601 in the Phase 1 APOLLO clinical trial. The participant, who had diffuse large B cell lymphoma and had failed four prior lines of therapy, demonstrated a complete metabolic response after treatment with MT-601. The treatment was well tolerated with no reports of higher than Grade 1 treatment-related adverse events. Following the news, MRKR shares are up 11.10% at $6.13.

Portfolio Pulse from Vandana Singh

September 11, 2023 | 5:46 pm

A significant amount of unusual options activity has been observed for Blackstone (NYSE:BX), with a majority of investors taking a bearish stance. The targeted price range for Blackstone over the last 3 months has been between $70.0 and $200.0. The current price of BX is up 1.54% at $114.41, with RSI indicators suggesting the stock may be overbought. Morgan Stanley has downgraded its action to Overweight with a price target of $125.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 5:46 pm

CGC

Shares of Canopy Growth are trading higher after the company's presentation at the Morgan Stanley 21st Annual Global Healthcare Conference 2023.

Portfolio Pulse from Bill Haddad

September 11, 2023 | 5:43 pm

ADM

Archer-Daniels-Midland (ADM) reported that its Decatur East plant, which produces soyoil and white flake for soy protein, along with an adjacent corn processing plant, are down following an explosion on Sunday.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 5:42 pm

ACIC

CRD

FGF

FIHL

HALL

HIPO

HRTG

MRAI

ROOT

SLQT

Insurance stocks experienced significant movement during Monday's intraday session. Gainers included SelectQuote (SLQT), Hallmark Financial Services (HALL), Fidelis Insurance Holdings (FIHL), American Coastal (ACIC), Hippo Holdings (HIPO), and Root (ROOT). Losers included Marpai (MRAI), FG Financial Group (FGF and FGFPP), Crawford (CRD), and Heritage Insurance Holdings (HRTG).

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 5:40 pm

CGC

Canopy Growth Corporation (NASDAQ:CGC) saw a surge of over 50% on Monday due to a change in sentiment in the cannabis sector, driven by the Department of Health and Human Services' proposal to reclassify marijuana to a lower-risk drug category. The company's stock has risen about 230% since August 30, indicating a high level of interest and a possible sector reversal. The stock is expected to trade sideways on Tuesday and possibly Wednesday, forming an inside bar pattern, which would lean bullish for a continuation higher.

Portfolio Pulse from Melanie Schaffer

September 11, 2023 | 5:36 pm